To Clot Or not Jason Corbeill PA-C. Thrombus—pathologic blood coagulation –Thrombi “embolize” and travel to new places Clot—the normal coagulation of.

Slides:



Advertisements
Similar presentations
The Basics of Hemophilia
Advertisements

Hemostasis Shaina Eckhouse 10/12/2010.
Chapter 12 Disorders of Hemostasis
J. Bormanis/ cg edits  When did it start ?  Dental history  Spontanous bruising  Bleeding at surgery  Bleeding into joints  Menstrual bleeding.
Bleeding Disorders For Surgeons
Bleeding and Thrombosis in Children Alice J. Cohen, M.D. Newark Beth Israel Medical Center.
Initiation substances activate s by proteolysis a cascade of circulating precursor proteins which leads to the generation of thrombin which in turn converts.
Bachelor of Chinese Medicine, The University of Hong Kong Bleeding disorders Dr. Edmond S. K. Ma Division of Haematology Department of Pathology The University.
Basic Principles of Hemostasis
Gatmaitan, Raymond Vincent Golpeo, Kirsten C.
MLAB 1227: Coagulation Keri Brophy-Martinez
Bleeding time,clotting time, PT, and PTT
Approach to the Bleeding Patient
Dr msaiem Acquired Coagulation Disorders Dr Mohammed Saiem Al-dahr KAAU Faculty of Applied Medical Sciences.
Protein C and Protein S Deficiency Paolo Aquino 18 February 2003.
Week 6: Secondary Hemostasis Plasmatic factors Plasmatic factors Intrinsic pathway Intrinsic pathway Extrinsic pathway Extrinsic pathway Specimen Specimen.
Week 7: Fibrinolysis and Thrombophilia Secondary fibrinolysis Secondary fibrinolysis Primary fibrinolysis Primary fibrinolysis Plasminogen Plasminogen.
Lecture NO- 12- Dr: Dalia Kamal Eldien.  Coagulation: Is the process by which blood changes from a liquid to a clot. Coagulation begins after an injury.
Bleeding time,clotting time, PT, and PTT
Dr Nico Lategan MBChB, MMed (Haematology)
Hemostasis and Blood Coagulation
MLAB Coagulation Keri Brophy-Martinez
FUNCTIONS OF THE COAGULATION SYSTEM ACTIONDESIRED RESULT Rapid formation of mechanically sound clot Stop bleeding quickly Prevent clot formation at non-injured.
HMIM BLOCK 224 PLATELET AND HEMOSTASIS Dr. Zahoor Lecture - 6.
Dr Mahvash Khan MBBS, MPhil. ◦ Occurs inside the blood vessels, it is also called fibrinolysis ◦ Occurs due to a substance known as plasmin (fibrinolysin)
Bleeding Disorders Dr. Farjah H.AlGahtani
Approach to Bleeding Disorders
APPROACH TO BLEEDING DISORDERS. History of Bleeding Spontaneous vs. trauma/surgery-induced Ecchymoses without known trauma Medications or nutritional.
Child with hematological dysfunction Emad Al Khatib, RN,MSN,CNS.
Coagulation Concepts A review of hemostasis Answers are in the notes pages.
Thrombophilia National Haemophilia Director
Bleeding Disorders JANUARY 19, 2012 Erin M. Kwolek.
Hypercoagulable States. Acquired versus inherited Acquired versus inherited “Provoked” vs idiopathic VTE “Provoked” vs idiopathic VTE Who should be tested.
Thrombophilia (Hypercoagulable States) Abdulkareem Almomen, MD Professor of Medicine & Hematology, King Saud University MED 341, Feb.2014.
Thrombophilia. Definition –Tendency to develop clots due to predisposing factors that may be genetically determined.
February 4 th, The Child With Pain Single Joint Involvement Multiple Joint Involvement With Fever Septic arthritis/Osteomyelitis Sympathetic arthritis.
Bleeding and Kristine Krafts, M.D. Thrombotic Disorders.
Hematology Blueprint PANCE Blueprint. Coagulation Disorders.
Deep vein thrombosis and pulmonary embolism.
HEMOSTASIS When blood vessels are cut or damaged, the loss of blood from the system must be stopped before shock and possible death occur. This is accomplished.
INHERITED DISORDERS OF COAGULATION von Willebrand Disease 1.
Hypercoagulable States
Haemostasis. Indications for hemostasis test – Identify patients presenting with bleeding that have a correctable bleeding tendency – Identify patients.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 26 Disorders of Hemostasis.
1. Normal haemostasis Haemostasis is the process whereby haemorrhage following vascular injury is arrested. It depends on closely linked interaction.
Hemostasis Is a complex process which causes the bleeding process to stop. It refers to the process of keeping blood within a damaged blood vessel. Dependent.
Approach to the Bleeding Child. Evaluation  History Current Bleeding Medical Family  Physical exam  Selected laboratory investigations.
Coagulation tests CBC- complete blood count
Coagulation and anti-coagulants March Normal physiology Patophysiology Diagnostic tests Anticoagulants Anticoagulants and anesthesia.
Chapter 23. Bleeding disorders associated with coagulopathy
Bleeding Tendency Dr. Mervat Khorshied Ass. Prof. of Clinical and Chemical Pathology.
Platelets. Fig Hemostasis the process by which the bleeding is stopped from broken vessels. steps involved: Vascular spasm. Platelets plug formation.
Congenital bleeding disorders
Bleeding disorders Deficiency of any of the clotting factors leads to excessive bleeding Most common and important bleeding disorders are due Vitamin K.
Approach To Bleeding Disorders In Neonates
Multiple choice questions
General Principles of Hemostasis Kristine Krafts, M.D.
Constituents of the blood: Platelets and plasma
Discounted Coagulation Profiles Clinical Laboratories.
Hemodynamic disorders (1 of 3)
Bleeding and Thrombotic Disorders.
Congenital bleeding disorders
Intrinsic pathway Formation of prothombin activator is the central event in the clotting pathway For its formation the pathway that is initiated by.
Bleeding and Thrombotic Disorders Kristine Krafts, M.D.
General Principles of Hemostasis Kristine Krafts, M.D.
Division of Clinical Hameatology
Hemostasis Hemostasis depends on the integrity of Blood vessels
Hemostasis and Coagulation
Presentation transcript:

To Clot Or not Jason Corbeill PA-C

Thrombus—pathologic blood coagulation –Thrombi “embolize” and travel to new places Clot—the normal coagulation of blood in the healthy body

How to make a clot Start the clot –Contact factors (intrinsic) –Tissue factors (extrinsic)

Grow the clot in a specific location FAST!!!!!

Stop the clot –There needs to be a means for modulating clot production

Destroy the clot –In an orderly fashion so as not to cause emboli.

Normally all of these steps are happening simultaneously throughout the body However, there can be a problem with any one of these steps resulting in either excess clot formation (hypercoagulable state) or not enough clot formation (bleeding tendency)

The players Starter Growers –Clotting factors –Thrombin –Platelets –VWF –Homocysteine –Lupus anticoagulant Anticardiolipin Ab Antiphospholipid Ab –Vit K –Factor V Leiden Stopper Destroyers –Protein C –Protein S –Antithrombin III –Plasmin –Medications such as Heparin Warfarin Aspirin/plavix

Sources of Bleeding Platelet dysfunction: –Petechiae –bruises Clotting factor dysfunction: –Hemorrhage joints muscles

Sources of Clot Reason for the clot 1. Too many clotting proteins. 2. Abnormal clotting proteins. 3. Too little thrombolysis. 4. Endothelial damage Location of the clot Arterial = platelet activation or endothelial damage Venous = stasis and factor activation, APS Both = abnormal clotting proteins or homocysteine

Screening tests for hemostasis –CBC/PLT –PT –aPTT –TT

Tests for prolonged PT or PTT –Mixing studies –Individual factor assays –D-dimer, FDP, fibrinogen-tests for DIC –Lupus anticoagulant –Clot stability assay (F XIII)

Tests for thrombosis –Protein C&S –Antithrombin III –Factor V Leiden –Homocysteine –Lupus anticoagulant

CASES

Case 1-Mr. D 55 y/o male presents with complaint of easy bruising Hx? PE?

Case 1-Mr. D Labs –Cbc normal –PT 20 (12) –PTT 48 (32) –What factor abnormality could cause a prolonged PT and PTT?

Case 1-Mr D Vit K dependent factors: –II, VII, IX, X and protein C and S

Case 1-Mr. D Diagnosis: hepatic insufficiency –Lack of production of Vit K –Leads to deficiency of Vit K dependent factors and protein C and S. Treat with Vit K (oral, IV, subq)

Case 2-Mr. H 35 y/o male presents with chest pain. He runs marathons Hx? PE? Cbc normal PT normal PTT normal

Case 2-Mr. H

What conditions would cause a young, healthy male to be in a hypercoagulable state? –Protein C deficiency –Protein S deficiency –Antithrombin III deficiency –Hyperhomocysteinemia

Case 2-Mr. H

Diagnosis—Hyperhomocysteinemia Treatement—vit B6/folate

Case 3-Isabel 4 y/o female presenting with rash post URI Recent URI lasting 4 days Now feels normal Little sister is ok Hx? PE?

Case 3-Isabel Labs –WBC 7 ( ) –Hgb 13 ( ) –PLT 9 ( ) –PT 11 (12) –PTT 28 (32)

Case 3-Isabel ITP-idiopathic thrombocytopenic purpura –Antibodies directed against platelets causing destruction of platelets in spleen Treatment: platelet transfusion if bleeding or less than 10k. Steroids/IVIG, splenectomy ? What would you have to include in your differential diagnosis if she was older, had confusion or AMS and creatinine (CR) was 2.5 (elevated)?

Case 4-Mrs. D 30 y/o female with metastatic breast cancer Admitted for left leg pain, found acetabular bony mets and fractures. This am on rounds, noticed left lower extremity edema 2-3+, dusky. Labs: CBC, PT, PTT normal

Case 4-Mrs. D DVT –Virchow’s triad-hypercoagulable state, venous stasis, intimal trauma –More Labs: D dimer positive but not very specific. –Treatment: anticoagulation (put the brakes on the cascade), elevate, compression stockings, hydration, IVC filter

Case 4-Mrs. D Try to avoid this…

Case 5-Howie 5 y/o with scalp wound that isn’t healing well-just keeps oozing. Has had delayed wound healing all of his life, bled more than expected with circumcision. Little brother seems to have similar problem

Case 5-Howie Family History: mother’s father died of bleeding ulcer age 49 PE: Labs: –PT 11 (12) –PTT 54 (32) –Cbc normal –More labs?

Case 5-Howie

Tests for prolonged PT or PTT –Mixing studies –Individual factor assays –D-dimer, FDP, fibrinogen-tests for DIC –Lupus anticoagulant –Clot stability assay (F XIII)

Case 5-Howie Mixing studies: Barium sulfate absorbed plasma: lacks II, VII, IX and X, but contains I, V, VIII and XIII. Serum: lacks I, V, VIII, and XIII, but contains II, VII, IX and X. Modification PTT Ref Pt + barium sulfate abs plasma 53 (22-34) Pt + serum 24 (22-34)

Case 5-Howie Factor IX deficiency (Hemophilia B) –Factors II and X are in common pathway and their deficiency would cause both PT and PTT elevation. –Factor VII is in the extrinsic pathway and it’s deficiency would cause elevated PT as well. –So it must be factor IX deficiency

Case 5-Howie Hemophilia A (factor VIII) deficiency Hemophilia B (factor IX) deficiency –X linked recessive –Severity depends on how much factor Treatment: Factor IX concentrates after wounds and prior to surgery

Case 5-Howie

Case 6-Mrs. R 35 y/o female presenting with joint stiffness, right leg pain and edema Hx fetal loss x 2 Maternal grandmother died of “blood clot in the lung” at age 40

Case 6-Mrs. R –PT 11 (12) –PTT 48 (32) –WBC 12.4 ( ) –Hgb 13.3 ( ) –PLT 118 ( ) –RF 126 (0-40) –ANA 1:80 (neg)

Case 6-Mrs. R Antiphospholipid Antibody Syndrome? –PTT prolonged in vitro only, patient is actually hypercoagulable –PTT will not correct with mixing study –Lupus anticoagulant –Check Anticardiolipin Ab –Anti beta 2 glycoprotein-I –ANA positive –Anti ss DNA –Antiphospholipid antibodies

Case 6-Mrs. R Treatment: –Heparin to coumadin. –Goal INR over 3. –What about the thrombocytopenia? Due to APL Ab binding to phospholipid on platelet cell surfaces.

Case 7-Mrs. KL 28 y/o female presents with easy bruising Bleeds excessively with dental procedures History of menorrhagia Pregnant with her first child FH significant for bleeding problems –Male and female –Scared because her aunt supposedly died in childbirth due to hemorrhage

Case 7-Mrs. KL Labs: –PT 11.2 (12) –PTT 42 (32) –WBC 11.2 ( ) –Hgb 11.2 ( ) –PLT 160( )

Case 7-Mrs. KL ? Von Willebrands Disease? Autosomal dominant –VWF is produced in the endothelial cells and platelets –Promotes platelet adhesion to endothelial cells and each other –Labs include VWF antigen (decreased) –Level of VWF Ristocetin cofactor activity (down) –Measurement of the activity of VWF

Case 7-Mrs. KL Why is PTT prolonged? –VWF also binds to FVIII to create a complex which ultimately promotes the conversion of X to Xa. –Decreased function of F VIII (as in hemophilia A)

Case 7-Mrs. KL Treatment: –Factor VIII concentrates –DDAVP (desamino-D-arginine vasopressin) Promotes the production of VWF

Case 8-Mr. P 22 y/o male hotel clerk presents with chest pain, sob, hemoptysis. VS: BP 138/88 R 36 P 96 Exam: CTA ABG –PO2 83 (80-100) –PCO2 26 (35-45) –pH 7.28 ( )

Case 8-Mr. P So, Mr. P has a pulmonary embolism. CT shows it but you susupected it sooner and have already given him heparin/LMWH. Why does he have a PE?

Case 8-Mr. P Reason for the clot 1. Too many clotting proteins. 2. Abnormal clotting proteins. 3. Too little thrombolysis. 4. Endothelial damage Location of the clot Arterial = platelet activation or endothelial damage Venous = stasis and factor activation, APS Both = abnormal clotting proteins or homocysteine

Case 8-Mr. P PT 11 (12) PTT 29 (24-34) CBC normal

Tests for thrombosis –Protein C&S –Antithrombin III –Factor V Leiden –Homocysteine –Lupus anticoagulant

Case 8-Mr. P Factor V Leiden –Leiden is an abnormal Factor V protein It is unable to be inhibited. 5% of the caucasian population has Factor V Leiden (1:20) Heterozygotes 7x increased risk clot Homozygotes 80x increased risk of clot

statistic 60% of inherited hypercoagulable states are due to: Factor V Leiden Prothrombin polymorphism Mutations of Protein C, S and antithrombin III

Case 8-Mr. P Lifelong coumadin